Devices & Diagnostics Letter

Feb. 6, 2012 | Vol. 39 No. 6

OIG to HHS: Flex Muscle to Curb Off-Label Promotion

Devicemakers could see a stronger crackdown on off-label promotion, according to a new Office of Inspector General (OIG) report that directs HHS to focus on the practice.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

First IDE Approval to Heart Societies Goes to Study Off-Label Sapien Use FDA Will Use Caronia to Develop New Guidance; No Further Appeals Planned Fewer Warning Letters on Marketing Likely in Wake of Caronia Verdict Defense Attorneys Predict No FDA Action on Caronia, but Off-Label Guidance Crucial

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.